HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MHC-restricted responses of CD8+ and CD4+ T-cell clones from regional lymph nodes of melanoma patients.

Abstract
Regional lymph-node (LN) lymphocytes may constitute an important defence against the spread of human melanoma beyond regional LNs. The present study was directed to clonal analysis of lymphocytes cultured either directly from the LNs or after stimulation in cultures with autologous melanoma (MLTC). T-cell clones derived from MLTC reactions had either CD4+ or CD8+ phenotypes. Inhibition studies with monoclonal antibodies (MAbs) suggested that the CD8+ cytotoxic T-cell (CTL) clones had MHC-class-I-restricted cytotoxic activity against the autologous and a proportion of HLA-class-I-compatible allogeneic melanomas. The pattern of cytotoxicity against a panel of HLA-typed melanoma cells and inhibition by (polyclonal) HLA-typing sera suggested the CD8+ CTL were restricted by HLA-A3. The CD4+ T-cell clones had weak cytotoxic activity which appeared restricted by HLA-DR2. T cells cultured from unstimulated lymphocytes were all CD4+. One of the clones exhibited cytotoxic activity against both the autologous and HLA-DR2-compatible allogeneic melanoma cells, whereas another 2 had cytotoxic activity only against a HLA-DR2-compatible allogeneic melanoma established from a primary melanoma. IL-2 production by a 4th non-cytotoxic clone had similar specificity. These results suggest that HLA-A3 and DR2 may act as restricting elements in recognition of melanoma antigens by T cells from LNs and that they may have recognized at least 2 different antigens on the melanoma cells.
AuthorsQ Chen, P Hersey
JournalInternational journal of cancer (Int J Cancer) Vol. 51 Issue 2 Pg. 218-24 (May 08 1992) ISSN: 0020-7136 [Print] United States
PMID1568790 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-A1 Antigen
  • HLA-A3 Antigen
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • Interleukin-2
Topics
  • Aged
  • Cell Division
  • HLA-A1 Antigen (immunology)
  • HLA-A3 Antigen (immunology)
  • Histocompatibility Antigens Class I (immunology)
  • Histocompatibility Antigens Class II (immunology)
  • Humans
  • Interleukin-2 (biosynthesis)
  • Lymph Nodes (immunology)
  • Lymphocyte Activation (immunology)
  • Major Histocompatibility Complex (immunology)
  • Male
  • Melanoma (immunology, pathology)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: